Rate My Professor Emily Don

Dr. Don's research specializes in developing molecular toolkits for zebrafish models of neurodegenerative diseases, creating transgenic lines for real-time in vivo studies of the nervous system. Her goals include genetically encoded reporters to investigate nervous system development, aging, and pathology. Notable publications encompass "Critical impact of lysine 136 in TDP-43 phase separation, compartmentalization, and aggregation in living vertebrates" (2025), "C9orf72-associated dipeptide repeat expansions perturb ER-golgi vesicular trafficking, inducing golgi fragmentation and ER stress, in ALS/FTD" (2024), "RNA-binding properties orchestrate TDP-43 homeostasis through condensate formation in vivo" (2024), "Treatment with sodium butyrate induces autophagy resulting in therapeutic benefits for spinocerebellar ataxia type 3" (2024), "CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia" (2016), and "A Tol2 Gateway-Compatible Toolbox for the Study of Prion-Related Neurodegeneration and Neuroprotection" (2016). Awards include the Biomedical Sciences Early Career Research Award (2018), Best Oral Presentation (2016), and multiple best presentation and poster awards (2015-2019). She contributes to committees like the School of Natural Sciences Education Committee, B.ClinSci Professional Practice working group, and the Executive Group of the Centre for Motor Neuron Disease Research.